Insulin Pump vs Multiple Daily Injections of Insulin and Glyco-metabolic Control in Type 1 Diabetic Patients
Status:
Recruiting
Trial end date:
2026-12-01
Target enrollment:
Participant gender:
Summary
The transition from the Pediatric clinic to the adult care is a challenging period for young
adults with type 1 diabetes, due to the high risk of poor glycemic control. Achieving the
glycemic target without hypoglycemia and/or large glucose excursions is of paramount
importance for type 1 diabetic patients, who have high variability of daily glucose levels .
Both insulin pump therapy and multiple daily injections of insulin are recommended strategy
to achieve glycemic control in type 1 diabetes; however, no studies investigated the effects
of insulin pump vs insulin injections on glycol-metabolic outcomes in the transition phase.
The aim of this study was to evaluate the effects of continuous subcutaneous insulin infusion
(CSII) therapy, as compared with multiple daily injections of insulin (MDI), on glycemic and
metabolic control, in young type 1 diabetic patients transitioned to the adult diabetes care.